Aging and insulin secretion

American Journal of Physiology - Endocrinology and Metabolism

Volumn 284, Issue 1 47-1, 2003, Pages

  Chang, Annette M ^a,c   Halter, Jeffrey B ^a,b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Aged humans; Cell function

Indexed keywords

GLUCOSE; HORMONE; INCRETIN; INSULIN; UNCLASSIFIED DRUG;

ADULT; AGED; AGING; CONTROLLED STUDY; DISEASE PREDISPOSITION; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE; HUMAN; HYPERGLYCEMIA; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; REVIEW;

EID: 0037227526     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.00366.2002     Document Type: Review

References (46)

1. Adelman R. Secretion of insulin during aging. J Am Geriatr Soc 37: 983-990, 1989.
2. Ahren B and Pacini G. Age-related reduction in glucose elimination is accompanied by reduced glucose effectiveness and increased hepatic insulin extraction in man. J Clin Endocrinol Metab 83: 3350-3356, 1998.
3. Andres R. Aging and diabetes. Med Clin North Am 55: 835-846, 1971.
4. Andres R. Aging, diabetes, and obesity: Standards of normality. Mt Sinai J Med 48: 489-295, 1981.
5. Andres R and Tobin JD. Aging and the disposition of glucose. Adv Exp Biol Med 61: 239-249, 1975.
6. Barrett-Connor E and Ferrara A. Isolated postchallenge hyperglycemia and the risk of fatal cardiovascular disease in older women and men. Diabetes Care 21: 1236-1239, 1998.
7. Bourey RE, Kohrt WM, Kirwan JP, Staten MA, King DS, and Holloszy JO. Relationship between glucose tolerance and glucose-stimulated insulin response in 65-year-olds. J Gerontol 48: M122-M127, 1993.
8. Chen M, Bergman RN, Pacini G, and Porte D Jr. Pathogenesis of age-related glucose intolerance in man: Insulin resistance and decreased β-cell function. J Clin Endocrinol Metab 60: 13-20, 1985.
9. Chen M, Halter JB, and Porte D Jr. Pathogenesis of agerelated glucose intolerance of the elderly. J Am Geriatr Soc 35: 417-424, 1987.
10. Chiasson JL, Josse RG, Gomis G, Hanefeld M, Karasik A, and Laakso M. Acarbose for the prevention of type 2 diabetes mellitus: The STOP-NIDDM randomized trial. Lancet 359: 2072-2077, 2002.
11. DECODE study group. Consequences of the new diagnostic criteria for diabetes in older men and women. Diabetes Care 22: 1667-1671, 1999.
12. DECODE study group. Glucose tolerance and mortality: Comparison of WHO and American Diabetes Association diagnostic criteria. Lancet 354: 617-621, 1999.
13. DeFronzo R. Glucose intolerance and aging. Diabetes Care 4: 493-501, 1981.
14. DeFronzo RA. Glucose intolerance and aging: Evidence for tissue insensitivity to insulin. Diabetes 28: 1095-1101, 1979.
15. Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346: 393-403, 2002.
16. Elahi D, Andersen DK, Muller DC, Tobin JD, Brown JC, and Andres R. The enteric enhancement of glucose-stimulated insulin release: The role of GIP in aging, obesity, and non-insulin-dependent diabetes mellitus. Diabetes 33: 950-957, 1984.
17. Feldman JM and Plonk JW. Effect of age on intravenous glucose tolerance and insulin secretion. J Am Geriatr Soc 24: 1-3, 1976.
18. Fink RI, Reyers RR, Kolterman OG, and Olefsky JM. The metabolic clearance of insulin and the feedback inhibition of insulin secretion are altered with aging. Diabetes 34: 275-280, 1985.
19. Garcia GV, Freeman RV, Supiano MA, Smith MJ, Galecki AT, and Halter JB. Glucose metabolism in older adults: A study including subjects more than 80 years of age. J Am Geriatr Soc 45: 813-817, 1997.
20. Gumbiner B, Polonsky KS, Beltz WF, Wallace P, Brechtel G, and Fink RI. Effects of aging on insulin secretion. Diabetes 38: 1549-1546, 1989.
21. Halter JB. Carbohydrate metabolism. In: Handbook of Physiology. Aging. Bethesda, MD: Am. Physiol. Soc., 1995, sect. 11, chapt. 7, p. 119-145.
22. Harris MI, Flegal KM, Cowie CC, Eberhardt MS, Goldstein DE, Little RR, Wiedmeyer HS, and Byrd-Holt DD. Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U. S. adults: The third National Health and Nutrition Examination Survey, 1988-1994. Diabetes Care 21: 518-524, 1998.
23. Harris MI, Hadden WC, Knowler WC, and Bennett PH. Prevalence of diabetes and impaired glucose tolerance and plasma glucose levels in U. S. population aged 30 to 74 yr. Diabetes 36: 523-534, 1987.
24. Kahn SE, Larson VG, Schwartz RS, Beard JC, Cain KC, Fellingham GW, Stratton JR, Cerqueira MD, and Abrass IB. Exercise training delineates the importance of B-cell dysfunction to the glucose intolerance of human aging. J Clin Endocrinol Metab 74: 1336-1342, 1992.
25. Korosi J, McIntosh CHS, Pedersen RA, Demuth HU, Habener JF, Gingerich R, Egan JM, Elahi D, and Meneilly GS. Effect of aging and diabetes on the enteroinsular axis. J Gerontol Med Sci 56A: M575-M579, 2001.
26. McConnell JG, Alam MJ, O'Hare MM, Buchanen KD, and Stout RW. The effect of age and sex on the response of enteropancreatic polypeptide to oral glucose. Age Ageing 12: 54-62, 1993.
27. McGuire EA, Tobin JD, Berman M, and Andres R. Kinetics of native insulin in diabetic, obese, and aged men. Diabetes 28: 110-120, 1979.
28. Meneilly GS, Demuth HU, McIntosh CHS, and Pederson RA. Effect of ageing and diabetes on glucose-dependent insulinotropic polypeptide and dipeptidyl peptidase IV responses to oral glucose. Diabet Med 17: 346-350, 2000.
29. Meneilly GS, Elliott T, Tessier D, Hards L, and Tildesley H. NIDDM in the elderly. Diabetes Care 19: 1320-1324, 1997.
30. Meneilly GS, Ryan AS, Minaker K, and Elahi D. The effect of age and glycemic level on the response of the β-cell to glucose-dependent insulinotropic polypeptide and peripheral tissue sensitivity to endogenously released insulin. J Clin Endocrinol Metab 83: 2925-2932, 1998.
31. Meneilly GS, Ryan AS, Veldhuis JD, Elahi D. Increased disorderliness of basal insulin release, attenuated insulin secretory burst mass, and reduced ultradian rhythmicity of insulin secretion in older individuals. J Clin Endocrinol Metab 82: 4088-4093, 1997.
32. Meneilly GS, Veldhuis JD, and Elahi D. Disruption of the pulsatile and entropic modes of insulin release during and unvarying glucose stimulus in elderly individuals. J Clin Endocrinol Metab 84: 1938-1943, 1999.
33. Minaker KL, Rowe JW, Tonino R, and Pallotta JA. Influence of age on clearance of insulin in man. Diabetes 31: 851-855, 1982.
34. Muller DC, Elahi D, Tobin JD, and Andres R. Insulin response during the oral glucose tolerance test: The role of age, sex, body fat and the pattern of fat distribution. Aging Clin Esp Res 8: 13-21, 1996.
35. Palmer JP and Ensinck JW. Acute-phase insulin secretion and glucose tolerance in young and aged normal men and diabetic patients. J Clin Endocrinol Metab 41: 498-503, 1975.
36. Pfeifer MA, Halter JB, and Porte D Jr. Insulin secretion in diabetes mellitus. Am J Med 70: 579-588, 1981.
37. Polonsky KS, Given BD, and Van Cauter E. Twenty-four-hour profiles and pulsatile patterns of insulin secretion in normal and obese subjects. J Clin Invest 81: 442-448, 1988.
38. Porte D Jr. Banting lecture 1990. Beta-cells in type II diabetes mellitus. Diabetes 40: 166-180, 1991.
39. Ranganath L, Sedgwick I, Morgan L, Wright J, and Marks V. The ageing entero-insular axis. Diabetologia 41: 1309-1313, 1998.
40. Reaven GM and Reaven EP. Age, glucose intolerance, and non-insulin dependent diabetes mellitus. J Am Geriatr Soc 33: 286-290, 1985.
41. Resnick HE, Harris MI, Brock DB, and Harris TB. American Diabetes Association diabetes diagnostic criteria, advancing age, and cardiovascular disease risk profiles. Diabetes Care 23: 176-180, 2000.
42. Roder ME, Schwartz RS, Prigeon RL, and Kahn SE. Reduced pancreatic B cell compensation to the insulin resistance of aging: Impact on proinsulin and insulin levels. J Clin Encrinol Metab 85: 2275-2280, 2000.
43. Rodriguez BL, Curb JD, Burchfiel CM, Huang B, Sharp D, Ye Lu G, Fujimoto W, and Katsuhiko Y. Impaired glucose tolerance, diabetes, and cardiovascular disease risk factor profiles in the elderly: The Honolulu Heart Program. Diabetes Care 19: 587-190, 1996.
44. Scheen AJ, Sturis J, Polonsky KS, and Van Cauter E. Alterations in the ultradian oscillations of insulin secretion and plasma glucose in aging. Diabetologia 39: 564-572, 1996.
45. Shimuzu M, Kawazu S, Tomono S, Ohno T, Utsugi T, Kato N, Ishii C, Ito Y, and Murata K. Age-related alteration of pancreatic beta-cell function: Increased proinsulin and proinsulin-to-insulin molar ratio in elderly, but not in obese, subjects without glucose intolerance. Diabetes Care 19: 8-11, 1996.
46. Wahl PW, Savage PJ, Psaty BM, Orchard TJ, Robbins JA, and Tracy RP. Diabetes in older adults: Comparison of 1997 American Diabetes Association classification of diabetes mellitus with 1985 WHO classification. Lancet 352: 1012-1015, 1998.